Effects of the Breath Stacking Technic in Healthy Individuals

February 1, 2017 updated by: Luciene Aparecida José Vaz, Federal University of Uberlandia
This study aims to Analyze and compere the hemodynamic and respiratory variables before, during and after the applying of technic as well as evaluate respiratory pressures generated during applying of this same technic and correlate them with the effort noticed by device user.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The breath stacking technic (BS) is an inspiratory maneuver used for recruitment of collapsed alveoli and, consequently, improves oxygenation and, therefore, used by respiratory physiotherapy aiming promoting lung re-expansion being. The BS was described by Marini as an attempt of optimizing vital capacity in little co-operative individuals and hemodynamics has been considered a way of incentive spirometry that provides high lung volume, in situations, in which, inspiratory maneuver duration can be as important as the volume reached, composing an alternative incentive of inspiration technic4. The system used is composed by an interface (facial mask) connected to the patient, an inspiratory unidirectional valve and the respiratory branch which is kept occluded during the carrying out of maneuvers.

Study Type

Observational

Enrollment (Actual)

52

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

52 healthy young volunteers The volunteers at the age of 18 to 30, sedentary: absence of neuromuscular and/or cardiac respiratory diseases were included, the smokers, overweight, claustrophobic or the ones with difficulty in carrying out the technic were excluded

Description

Inclusion Criteria:

  • age of 18 to 30, sedentary, absence of neuromuscular and/or cardiac respiratory diseases

Exclusion Criteria:

  • the smokers, overweight, claustrophobic or the ones with difficulty in carrying out the technic

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Breath stacking
During initial rest period, the volunteer remained seated for 10' in spontaneous breathing. During carrying out of the breath stacking technic, the volunteer remained seated, being requested to hold the mask on his/her face not allowing air scape, The volunteer was oriented to inhale normally and exhale all the air during expiration for 20 seconds. During the 20 seconds of applying of technic, in the three series the maximum inspiratory and expiratory pressures reached during the carrying out of technic. In the final rest period, right after technic end, the volunteers remained seated for 10 minutes in spontaneous breathing and again the same variables of control at the 10th minute were assessed.
During initial rest period, the volunteer remained seated for 10' in spontaneous breathing. Right after, the measurement of arterial pressure, of SpO2 (%), of heart rate, of respiratory frequency and applied to a modified effort perception Borg. During carrying out of the breath stacking technic, the volunteer remained seated, being requested to hold the mask on his/her face not allowing air scape, The volunteer was oriented to inhale normally and exhale all the air during expiration for 20 seconds, and the variables were assessement again the same variables of control. In the final rest period, right after technic end, the volunteers remained seated for 10 minutes in spontaneous breathing and again the same variables of control at the 10th minute were assessed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
maximum inspiratory and expiratory pressures
Time Frame: During the intervention. They will be used to verify the average pressures generated during the execution of the technique. Time of the technique equal to 20 seconds.
connected to a manometer from brand Commercial Medica (Brazil) used to measure maximum inspiratory and expiratory pressures generated during carrying out of technic. The volunteer was oriented to inhale normally and exhale all the air during expiration for 20 seconds.
During the intervention. They will be used to verify the average pressures generated during the execution of the technique. Time of the technique equal to 20 seconds.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
modified effort perception Borg scale
Time Frame: Before, during and after the intervention. They will be used to compare the variation before, during and after the technique. Valuation time was 1 minute.
applied to a modified effort perception Borg scale with a score from 0 to 10, considering 0 the smallest effort noticed and 10 the biggest effort reported
Before, during and after the intervention. They will be used to compare the variation before, during and after the technique. Valuation time was 1 minute.
heart rate
Time Frame: Before, during and after the intervention. They will be used to compare the variation before, during and after the technique. Valuation time was 1 minute.
by palpation method of radial artery, of respiratory frequency by direct counting of thoracic movement
Before, during and after the intervention. They will be used to compare the variation before, during and after the technique. Valuation time was 1 minute.
peripheral oxygen saturation
Time Frame: Before, during and after the intervention. They will be used to compare the variation before, during and after the technique. Valuation time was 1 minute.
through a pulse oximeter
Before, during and after the intervention. They will be used to compare the variation before, during and after the technique. Valuation time was 1 minute.
systolic arterial pressure
Time Frame: Before, during and after the intervention. They will be used to compare the variation before, during and after the technique. Valuation time was 1 minute.
the measurement of systolic arterial pressure were assessed using an aneroid-type sphygmomanometer
Before, during and after the intervention. They will be used to compare the variation before, during and after the technique. Valuation time was 1 minute.
diastolic arterial pressure
Time Frame: Before, during and after the intervention. They will be used to compare the variation before, during and after the technique. Valuation time was 1 minute.
the measurement of systolic arterial pressure were assessed using an aneroid-type sphygmomanometer from the brand Lamedial Commercial
Before, during and after the intervention. They will be used to compare the variation before, during and after the technique. Valuation time was 1 minute.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

September 1, 2013

Study Registration Dates

First Submitted

January 24, 2017

First Submitted That Met QC Criteria

February 1, 2017

First Posted (Estimate)

February 3, 2017

Study Record Updates

Last Update Posted (Estimate)

February 3, 2017

Last Update Submitted That Met QC Criteria

February 1, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • CEP/UFU 364/11

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodynamic Instability

Clinical Trials on Breath stacking

Subscribe